SCHEMBL845501

SCHEMBL845501

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3nccc4ccccc34)cc2)cc1)[C@@H]1CCCN1C(=O)c1nccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.47
TRPV1 Q8NER1 2/20 0.46
ALDH1A1 P00352 3/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PABPC1 P11940 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 1/20 0.41
RHOC P08134 1/20 0.41
RHOA P61586 1/20 0.41
GAA P10253 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
DGAT1 O75907 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119513 0.91 JAK2 (0.41) HCRTR1TRPV1ALDH1A1CYP2C9CYP2C19
SCHEMBL18887556 0.88 HCRTR1 (0.47) HCRTR1TRPV1ALDH1A1CYP2C9CYP2C19
SCHEMBL13272267 0.88 HCRTR1 (0.42) HCRTR1TRPV1ALDH1A1CYP2C9CYP2C19
SCHEMBL12489817 0.87 HCRTR1 (0.47) HCRTR1TRPV1ALDH1A1CYP2C9CYP2C19
SCHEMBL4919272 0.85 HCRTR1 (0.52) HCRTR1TRPV1
SCHEMBL4919265 0.85 HCRTR1 (0.52) HCRTR1TRPV1
SCHEMBL845039 0.84 TRPV1 (0.51) HCRTR1TRPV1ALDH1A1CYP2C9CYP2C19
SCHEMBL845442 0.83 CYP2C9 (0.43) TRPV1ALDH1A1CYP2C9CYP2C19PABPC1
SCHEMBL12489636 0.82 TRPV1 (0.43) HCRTR1TRPV1ALDH1A1CYP2C9CYP2C19
SCHEMBL845697 0.82 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed